# Smart Angioplasty Research Team-Optimal Strategy for Side Branch Stenting in Coronary Bifurcation Lesion With Drug-Coated Balloon

> **NCT07019350** · NA · RECRUITING · sponsor: **Samsung Medical Center** · enrollment: 520 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **OTHER:** Upfront DCB-based hybrid strategy
- **OTHER:** Upfront 2-stenting strategy

## Key facts

- **NCT ID:** NCT07019350
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-22
- **Primary completion:** 2030-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 520 (ESTIMATED)
- **Last updated:** 2025-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07019350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07019350, "Smart Angioplasty Research Team-Optimal Strategy for Side Branch Stenting in Coronary Bifurcation Lesion With Drug-Coated Balloon". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07019350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*